Clinical trial
Depression Study In Elderly Patients
NCT00067444 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00067444 |
|---|---|
| Title | Depression Study In Elderly Patients |
| Official title | A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Fixed Dose Study Evaluating the Efficacy and Safety of Paroxetine CR in Elderly Outpatients Diagnosed With Major Depressive Disorder |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Depressive Disorder, Major, Major Depressive Disorder (MDD) |
| Intervention type | Drug |
| Interventions | Paroxetine CR |
| Enrollment | 560 |
| Start date | Jun 1, 2003 |
| Primary completion | Jan 1, 2005 |
| Completion | Jan 1, 2005 |
| First posted | Aug 21, 2003 |
| Last update posted | Sep 1, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: